Our Ref: FOI 22/1076

Dear Ann McNeil,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 31st October 2022.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000

show quoted sections

FOI 22/1076

Dear Ann McNeil,

Thank you for your email.

The breakdown of our income for the previous two financial years can be
found in the annual reports.

[1]MHRA_Annual_Report_and_Accounts_2021-22.pdf (publishing.service.gov.uk)

[2]MHRA_Annual_Report_and_Accounts_2020-21.pdf (publishing.service.gov.uk)

We are an executive agency of the Department of Health and Social Care.
Our 21/22 annual report contains information on page 13 and 48 regarding
our funding. If you require more details, please refer to the financial
statements - page 126 onwards. Notes 3.1 and 3.2 detail the breakdowns of
each source.

The below extract is taken from page 145.

Last year our activities were funded as follows:

• Medicines regulation was funded from fees charged to the regulated
industry according to the full cost recovery rules set out in Her
Majesty’s Treasury’s Managing Public Money
• Devices regulation was primarily funded by DHSC with approximately 10%
of its revenue from fees charged for services
• NIBSC derived almost half its revenue from fees charged for services,
including the sale of biological standards; NIBSC also received
research funding, including DHSC research funding through the
Regulatory Science Research Unit (RSRU); and DHSC provided the
remaining funding to finance its important public health functions
• CPRD is jointly funded by the Agency and DHSC’s National Institute for
Health Research (NIHR) and managed and operated by the Agency with
DHSC having equal voting rights in direction setting and decision
making

If you have a query about the information provided, please reply to this
email.

If you disagree with how we have interpreted the Freedom of Information
Act 2000 in answering your request, you can ask for an internal review.
Please reply to this email, within two months of this reply, specifying
that you would like an Internal Review to be carried out.

Please remember to quote the reference number above in any future
communications.

If you were to remain dissatisfied with the outcome of the internal
review, you would have the right to apply directly to the Information
Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless
you have first contacted us to conduct an internal review. The Information
Commissioner can be contacted at:

Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

Yours sincerely

MHRA Customer Experience Centre

Communications and engagement team

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000

show quoted sections

MHRA Customer Services would like to recall the message, "FOI 22/1076 - Freedom of Information request - Funding of MHRA".

DISCLAIMER This email and any files transmitted with it are confidential. If you are not the intended recipient, any reading, printing, storage, disclosure, copying or any other action taken in respect of this email is prohibited and may be unlawful. If you are not the intended recipient, please notify the sender immediately by using the reply function and then permanently delete what you have received. Incoming and outgoing email messages are routinely monitored for compliance with the Department of Health's policy on the use of electronic communications. For more information on the Department of Health's email policy, click DHTermsAndConditions<https://www.gov.uk/help/terms-conditions>

FOI 22/1076

Dear Ann McNeil,

Thank you for your email.

The breakdown of our income for the previous two financial years can be
found in the annual reports.

[1]MHRA_Annual_Report_and_Accounts_2021-22.pdf (publishing.service.gov.uk)

[2]MHRA_Annual_Report_and_Accounts_2020-21.pdf (publishing.service.gov.uk)

We are an executive agency of the Department of Health and Social Care.
Our 21/22 annual report contains information on page 13 and 48 regarding
our funding. If you require more details, please refer to the financial
statements - page 126 onwards. Notes 3.1 and 3.2 detail the breakdowns of
each source.

The below extract is taken from page 145.

Last year our activities were funded as follows:

• Medicines regulation was funded from fees charged to the regulated
industry according to the full cost recovery rules set out in Her
Majesty’s Treasury’s Managing Public Money
• Devices regulation was primarily funded by DHSC with approximately 10%
of its revenue from fees charged for services
• NIBSC derived almost half its revenue from fees charged for services,
including the sale of biological standards; NIBSC also received
research funding, including DHSC research funding through the
Regulatory Science Research Unit (RSRU); and DHSC provided the
remaining funding to finance its important public health functions
• CPRD is jointly funded by the Agency and DHSC’s National Institute for
Health Research (NIHR) and managed and operated by the Agency with
DHSC having equal voting rights in direction setting and decision
making

If you have a query about the information provided, please reply to this
email.

If you disagree with how we have interpreted the Freedom of Information
Act 2000 in answering your request, you can ask for an internal review.
Please reply to this email, within two months of this reply, specifying
that you would like an Internal Review to be carried out.

Please remember to quote the reference number above in any future
communications.

If you were to remain dissatisfied with the outcome of the internal
review, you would have the right to apply directly to the Information
Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless
you have first contacted us to conduct an internal review. The Information
Commissioner can be contacted at:

Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

Yours sincerely

MHRA Customer Experience Centre

Communications and engagement team

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000

show quoted sections